Article information
Abstract
Strongyloides stercoralis (S.S.) is a human intestinal parasite, which may lead to complicated strongyloidiasis. We report a case of disseminated strongyloidiasis following the treatment of myeloma. The patient developed skin lesions, respiratory distress, aseptic meningitis and bacterial and fungal sepsis. The diagnosis of strongyloidiasis was established through endotracheal tube secretions. Despite the treatment with Ivermectin and Albendazole, the outcome was fatal. The value of screening for strongyloidiasis is unclear but may be of benefit in patients with hematological malignancies from high endemic areas.
Keywords:
acute respiratory failure
disseminated strongyloidiasis
myeloma
steroids
Full text is only available in PDF
References
[1.]
A.A. Siddiqui, S.L. Berk.
Diagnosis of Strongioloides stercoralis Infection.
Clin Infect Dis, 33 (2001), pp. 1040-1047
[2.]
R.M. Genta.
Global prevalence of strongyloidiasis: Critical review with epidemiologic insights into the prevention disseminated disease.
Rev Infect Dis, 11 (1989), pp. 755-767
[3.]
P.B. Keiser, T.B. Nutman.
Strongyloides stercoralis in the immunocompromised population.
Clin Microbiol Rev, 17 (2004), pp. 208-217
[4.]
C.J. Hunter, M. Petrosyan, M. Asch.
Dissemination of Strongyloides stercoralis in a patient with systemic lupus erythematous after initiation of Albendazole: A case report.
J Med Case Report, 2 (2008), pp. 156-164
[5.]
S. Namisato, K. Motomura, S. Haranaga, et al.
Pulmonary strongyloidiasis in a patient receiving prednisolone therapy.
Inter Med, 43 (2004), pp. 731-735
[6.]
M.S. Newnham.
Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
Ann Pharmacother, 41 (2007), pp. 1992-2001
[7.]
H. Orlent, C. Crawley, K. Cwynarski, R. Dina, J. Apperly.
Strongyloidiasis pre and post Autologous peripheral blood stem cell transplantation.
Bone Marrow Transplant, 32 (2003), pp. 115-117
[8.]
E.M. Carvalho, Dafonseca, A. Porto.
Epidemiological and clinical interaction Between HTLV-1 and Strongyloides stercoralis.
Parasites Immunol, 26 (2004), pp. 487-497
[9.]
H.L. Rotman, W. Yutanawiboonchai, R.A. Brigande, et al.
Strongyloidess stercoralis: Eosinophil-dependant immune-mediated killing of third stage larvae in BALB/cByJ mice.
Exp Parasitol, 82 (1996), pp. 267-278
[10.]
R. Concha, W. Harrington, A.I. Rogers.
Intestinal strongyloidiasis recognition management, and determinant of outcomes.
J Clin Gastrointerol, 39 (2005), pp. 203-211
[11.]
A.M. Newberry, D.N. Williams, W.M. Stauffer, et al.
Strongyloides hyperinfection presenting as acute respiratory failure and gramnegative sepsis.
Chest, 128 (2005), pp. 3681-3684
[12.]
S. Lim, K. Katz, S. Kratjden, et al.
Complicated and fatal strongyloides infection in Canadian: risk factors, diagnosis and management.
CMAJ, 171 (2004), pp. 479-484
[13.]
R. Igual-Adell, C. Oltra-Alcaraz, E. Soler-Company, et al.
Efficacy and safety of Ivermectin and Thiabendazole in the treatment of strongyloidiasis.
Expert Opinion Pharmacother, 5 (2004), pp. 2615-2619
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
